Achieve Life Sciences, Inc.
Income Statement
| Line Item | FY2019 | FY2018 |
|---|---|---|
| Revenue | $0 | $0 |
| Cost of Revenue | — | — |
| Gross Profit | — | — |
| Gross Margin | — | — |
| Operating Expenses | ||
| Research & Development | $9.7M | $5.9M |
| SG&A Expense | $6.9M | $6.9M |
| Operating Income | $-16.4M | $-12.7M |
| Operating Margin | — | — |
| Interest Expense | — | — |
| Pretax Income | $-16.4M | $-12.7M |
| Income Tax Expense | — | — |
| Net Income | $-16.4M | $-12.7M |
| Net Margin | — | — |
| EPS (Basic) | $-13.25 | $-24.10 |
| EPS (Diluted) | $-13.25 | $-24.10 |
| Shares Outstanding (Basic) | 4.4M | 20.2M |
| Shares Outstanding (Diluted) | 4.4M | 20.2M |
| Dividends Per Share | — | — |